Showing results (241-250 of 344) with videos related to
Sort By:
Pageof 35
Journal of Alzheimer'S Disease : JAD|September 25, 2015
CXCL1 Triggers Caspase-3 Dependent Tau Cleavage in Long-Term Neuronal Cultures and in the Hippocampus of Aged Mice: Implications in Alzheimer's DiseaseXiao-Fang Zhang, Yan-Feng Zhao, Shun-Wei Zhu, et al.BMC Ophthalmology|January 11, 2020
Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitorsEunhae Shin, Dong Hui Lim, Jisang Han, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2023
Programmed Death-Ligand 1 Copy Number Alteration as an Adjunct Biomarker of Response to Immunotherapy in Advanced NSCLCTae Hee Hong, Yeong Hak Bang, Cheol Yong Joe, et al.Translational Lung Cancer Research|March 18, 2024
Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analysesSehhoon Park, Jun-Kyu Kang, Naeun Lee, et al.Cancer Chemotherapy and Pharmacology|April 24, 2015
A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation testMoon Ki Choi, Jung Yong Hong, Won Jin Chang, et al.Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trialSung Won Lim, Sehhoon Park, Youjin Kim, et al.Journal of Neuro-Oncology|September 17, 2015
Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancerKyung Rae Cho, Min Ho Lee, Doo-Sik Kong, et al.Journal for Immunotherapy of Cancer|May 18, 2019
Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinomaSehhoon Park, Je-Gun Joung, Yang Won Min, et al.Investigational New Drugs|April 10, 2017
Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumorsSu Jin Lee, Seon Young Lee, Weon Sup Lee, et al.Cancer Research and Treatment|August 4, 2011
Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancerSu Jin Lee, Silvia Park, Hee Kyung Ahn, et al.Pageof 35